MedPath

BAR-502

Generic Name
BAR-502

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects

Phase 1
Withdrawn
Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
Drug: Placebo
First Posted Date
2022-01-24
Last Posted Date
2024-06-20
Lead Sponsor
BAR Pharmaceuticals s.r.l.
Registration Number
NCT05203367
Locations
🇵🇹

BlueClinical Phase I, Porto, Portugal

© Copyright 2025. All Rights Reserved by MedPath